World CB & CDx Summit | Boston
Wednesday, October 7th • 7:00AM • Westin Seaport, Marina Ballroom III
Breakfast provided | Limited seating
Reach out to secure your spot!
HLA as a Companion Diagnostic: What Does It Take to Make It Work in a Clinical Trial?
As precision medicines increasingly rely on HLA-specific biology, sponsors face a new challenge: translating HLA testing from an established clinical discipline into a scalable component of drug development.
During this interactive breakfast briefing at World CDx Boston, experts from Versiti Clinical Trial Solutions, Arc and GenDx will explore the scientific, operational and regulatory considerations involved in incorporating HLA testing into clinical trials and companion diagnostic strategies.
The panel will discuss practical challenges surrounding testing strategy, patient identification and enrollment, trial implementation, testing accessibility and scalability, and regulatory planning—with an emphasis on lessons sponsors can apply to emerging HLA-restricted programs.
Designed as a conversation rather than a presentation, the session will give attendees an opportunity to engage directly with experts working across HLA, diagnostics and clinical development.
